+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Middle East & Africa Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product, Method, Application and End User- Product Image
Middle East & Africa Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product, Method, Application and End User- Product Image
Sale

Middle East & Africa Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product, Method, Application and End User

  • PDF Icon

    Report

  • 108 Pages
  • July 2024
  • Region: Africa, Middle East
  • The Insight Partners
  • ID: 6006651
UP TO OFF until Dec 31st 2024
Description Jump to:
The Middle East & Africa transfection reagents and equipment market was valued at US$ 46.15 million in 2022 and is expected to reach US$ 80.53 million by 2030; it is estimated to register at a CAGR of 7.2% from 2022 to 2030.

Increasing Popularity of Cell and Gene Therapy Bolsters Middle East & Africa Transfection Reagents and Equipment Market

Cell and gene therapy manufacturing is a complicated process, which makes its execution and monitoring critical. Advancements in biotechnology have led to the adoption of personalized treatments for the treatment of numerous indications. Cell and gene therapies mostly are used to treat chronic diseases such as neurological disorders, cancer, and genetic disorders. The noteworthy advantages of cell and gene therapy include targeted treatment, faster and more efficient recovery, and reduced side effects. Cell and gene therapies are widely adopted across the world owing to the availability of Food and Drug Administration (FDA) approved products.

For instance, the FDA approved an adenovirus ADSTILADRIN manufactured by Ferring Pharmaceuticals A/S in 2022. This recombinant adenovirus (rAd-IFNa/Syn3) delivers human interferon alfa-2b cDNA into the bladder epithelium to treat patients suffering from certain types of bladder cancer. In 2022, CARVYKTI, manufactured by Janssen Biotech, Inc., was also approved by the FDA.

CARVYKTI is an autologous CAR-T cell engineered with lentivirus to attack BCMA-expressing tumor cells for the treatment of certain kinds of relapsed or refractory multiple myeloma. Scientists are nowadays employing the transfection technique for the production of these therapies. Hence, an upsurge in the popularity of cell and gene therapy activities fuels the number of transfection procedures performed, which, in turn, fuels the growth of the Middle East & Africa transfection reagents and equipment market.

Middle East & Africa Transfection Reagents and Equipment Market Overview

Middle East and Africa region is classified into Saudi Arabia, South Africa, United Arab Emirates, and Rest of Middle East and Africa. Saudi Arabia hold the largest market share in the year 2022.

The growth of the pharmaceutical industry in Middle East and Africa is widely driven by investments made by multinational pharmaceutical companies in countries such as Saudi Arabia, South Africa, United Arab Emirates, and more. In January 2023, Saudi Arabia's Ministry of Investment signed two memorandums of understanding to improve joint cooperation with the biotechnology and medicine industries in the kingdom. The ministry signed one agreement with Boehringer Ingelheim, a German company, for the enhancement of the pharmaceutical industry.

The second MoU was signed with Novo Nordisk Saudi Arabia and King Abdullah University of Science and Technology with an aim to contribute to providing solutions for developing community awareness about the concepts of metabolic disorders, obesity, and diabetes. Such efforts made to make people aware of rare and chronic medical conditions are likely to bolster the transfection reagents and equipment market in Saudi Arabia in the coming years.

Furthermore, partnerships between companies in these countries propelling the market growth, in December 2021, Secondcell Bio and Alliance Care Technologies International announced a new strategic partnership for establishing a novel, cutting-edge research facility focused on cell therapy and rapid drug discovery for combating rare genetic diseases in the UAE. The Chromovert technology is far ahead of CRISPR, and it has extensive potential to streamline the drug discovery process by enabling the generation of cells that were previously designed for improved drug discovery.

Middle East & Africa Transfection Reagents and Equipment Market Segmentation

The Middle East & Africa transfection reagents and equipment market is segmented based on product, method, application, end user, and country.
  • Based on product, the Middle East & Africa transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.
  • In terms of method, the Middle East & Africa transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is sub categorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.
  • By application, the Middle East & Africa transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.
  • Based on end user, the Middle East & Africa transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.
  • Based on country, the Middle East & Africa transfection reagents and equipment market is categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa transfection reagents and equipment market in 2022.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, and MaxCyte Inc are some of the leading companies operating in the Middle East & Africa transfection reagents and equipment market.

Table of Contents

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 Middle East & Africa Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 Middle East & Africa Transfection Reagents and Equipment Market Forecast Analysis
6. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East and Africa Transfection Reagents and Equipment Market -Country Analysis
10.1 Middle East and Africa
10.1.1 Middle East and Africa Transfection Reagents and Equipment Market Overview
10.1.2 Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.2.1 Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.2.2 Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.2.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.2.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.2.3 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.2.4 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.3 South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.3.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.3.2.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.3.2.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.3.2.2.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.3.2.2.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.3.3 South Africa: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.3.4 South Africa: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.4 United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.4.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.4.2.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.4.2.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.4.2.2.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.4.2.2.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.4.3 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.4.4 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.5 Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.5.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.5.2.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.5.2.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.5.2.2.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.5.2.2.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.5.3 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.5.4 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by End Users
10.2 Inorganic Growth Strategies
10.2.1 Overview
10.3 Organic Growth Strategies
10.3.1 Overview
11. Company Profiles
11.1 Thermo Fisher Scientific Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Promega Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bio-Rad Laboratories Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Mirus Bio LLC
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 QIAGEN NV
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Merck KGaA
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Lonza Group AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 MaxCyte Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About Us
LIST OF TABLES
Table 1. Middle East & Africa Transfection Reagents and Equipment Market Segmentation
Table 2. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 37. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 38. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 39. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 40. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 41. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 42. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 43. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 44. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 45. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
LIST OF FIGURES
Figure 1. Middle East & Africa Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Middle East & Africa Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Middle East and Africa: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Companies Mentioned

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc

Related Topics

Related Reports

Transfection Reagents and Equipment Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Method, Application, End User, and Geography - Product Image

Transfection Reagents and Equipment Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Method, Application, End User, and Geography

  • Report
  • 241 Pages
  • Global
From
Transfection Reagents & Equipment Market by Product, Method, Application, End User - Global Forecast 2025-2030 - Product Image

Transfection Reagents & Equipment Market by Product, Method, Application, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Transfection Reagents and Equipment Market Report by Product, Technology, Application, End User, and Region 2024-2032 - Product Image

Transfection Reagents and Equipment Market Report by Product, Technology, Application, End User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Transfection Reagents and Equipment Global Market Report 2024 - Product Image

Transfection Reagents and Equipment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Transfection Reagents & Equipment Market Size, Share & Trends Analysis Report, By Product, By Method (Electroporation), By Application (Transgenic Models), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Transfection Reagents & Equipment Market Size, Share & Trends Analysis Report, By Product, By Method (Electroporation), By Application (Transgenic Models), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Transfection Reagents Market

The Transfection Reagents market within the context of Genomics is a specialized market that focuses on the development and production of reagents used in the transfection process. Transfection is a process used to introduce genetic material into a cell, and is a key step in the genomics research process. Transfection reagents are used to facilitate the delivery of genetic material into the cell, and can be either chemical or biological in nature. These reagents are used in a variety of genomics applications, including gene expression, gene silencing, and gene editing. The Transfection Reagents market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include Thermo Fisher Scientific, Merck KGaA, Promega Corporation, Lonza Group, and QIAGEN. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.